1、Accelerating Biopharmaceutical Breakthroughs with an Innovative Enterprise Data StrategyShri Chary|Managing Director and AI&Data Leader,Deloitte Consulting LLPJune 2025Meet the SpeakerShri CharyManaging Director and AI&Data Leader,Deloitte Consulting LLPForward-looking StatementThis presentation has
2、 been prepared for informational purposes only.The information set forth herein does not purport to be complete or contain all relevant information.Statements contained herein are made as of the date of this presentation unless stated otherwise.This presentation and the accompanying oral commentary
3、may contain forward-looking statements.In some cases,forward-looking statements can be identified by terms such as“may”,“will”,“should”,“expects”,“plans”,“anticipates”,“could”,“intends”,“projects”,“believes”,“estimates”,“predicts”,or“continue”,or the negative of these words or other similar terms or
4、 expressions that concern Databricks expectations,strategy,plans,or intentions.Forward-looking statements are based on information available at the time those statements are made and are inherently subject to risks and uncertainties that could cause actual results to differ materially from those exp
5、ressed in or suggested by the forward-looking statements.Forward-looking statements should not be read as a guarantee of future performance or outcomes.Except as required by law,Databricks does not undertake any obligation to publicly update or revise any forward-looking statement,whether as a resul
6、t of new information,future developments or otherwise.4Macro trends are creating the need for biopharma companies to reimagine how they manage data as a strategic asset5Evolving market forces are shaping the broader data and analytics landscapeNew Vendor EntrantsProliferation Of DataSiloed SourcingD